Spark Biomedical Secures Wellcome Leap Funding to Advance Women's Health Neurostimulation Technology
Spark Biomedical's recent funding from Wellcome Leap will enable FDA-style clinical trials for its OhmBody wearable neurostimulation device, which has shown promising results in reducing menstrual bleeding and symptoms, representing a significant advancement in addressing long-neglected women's health needs.
